Clinical Trial Update: An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase) [Phase 2]

View source ↗

Summary

Phase 2 open-label PK study of intramuscular Erwinaze (asparaginase Erwinia chrysanthemi) / Erwinase (crisantaspase) for acute lymphoblastic leukemia and lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Drugs mentioned

• Erwinase (L-asparaginase from Erwinia chrysanthemi)
• Erwinaze (Asparaginase from Erwinia chrysanthemi)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) | Phase 2 | Status: WITHDRAWN